Swedish dialysis firm launches IPO

By Sam Kerr
16 Nov 2020

Diaverum, the Swedish operator of kidney dialysis clinics, has launched an IPO on the Nasdaq Stockholm.

Carnegie, JP Morgan and SEB are global co-ordinators on the deal. BNP ParibasCiti and Danske Bank are bookrunners.

Diaverum is seeking to raise €290m by selling new shares. There will also be a secondary share sale by Diaverum’s principle owner, Diaverum Holding, a vehicle owned by Bridgepoint.

The company intends to ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial